Logo image of RBBN

RIBBON COMMUNICATIONS INC (RBBN) Stock Fundamental Analysis

NASDAQ:RBBN - Nasdaq - US7625441040 - Common Stock - Currency: USD

3.835  -0.12 (-2.91%)

Fundamental Rating

4

Overall RBBN gets a fundamental rating of 4 out of 10. We evaluated RBBN against 48 industry peers in the Communications Equipment industry. While RBBN is still in line with the averages on profitability rating, there are concerns on its financial health. RBBN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year RBBN was profitable.
In the past year RBBN had a positive cash flow from operations.
In the past 5 years RBBN reported 4 times negative net income.
RBBN had a positive operating cash flow in 4 of the past 5 years.
RBBN Yearly Net Income VS EBIT VS OCF VS FCFRBBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

RBBN has a Return On Assets (-3.89%) which is in line with its industry peers.
The Return On Equity of RBBN (-11.98%) is worse than 60.42% of its industry peers.
RBBN's Return On Invested Capital of 3.11% is fine compared to the rest of the industry. RBBN outperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA -3.89%
ROE -11.98%
ROIC 3.11%
ROA(3y)-6.09%
ROA(5y)-5.14%
ROE(3y)-15.65%
ROE(5y)-13.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBBN Yearly ROA, ROE, ROICRBBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

RBBN's Operating Margin of 3.78% is fine compared to the rest of the industry. RBBN outperforms 60.42% of its industry peers.
In the last couple of years the Operating Margin of RBBN has grown nicely.
The Gross Margin of RBBN (51.12%) is better than 66.67% of its industry peers.
In the last couple of years the Gross Margin of RBBN has remained more or less at the same level.
Industry RankSector Rank
OM 3.78%
PM (TTM) N/A
GM 51.12%
OM growth 3Y16.11%
OM growth 5Y34.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.05%
GM growth 5Y-1.31%
RBBN Yearly Profit, Operating, Gross MarginsRBBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RBBN is destroying value.
Compared to 1 year ago, RBBN has more shares outstanding
The number of shares outstanding for RBBN has been increased compared to 5 years ago.
Compared to 1 year ago, RBBN has a worse debt to assets ratio.
RBBN Yearly Shares OutstandingRBBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
RBBN Yearly Total Debt VS Total AssetsRBBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.45, we must say that RBBN is in the distress zone and has some risk of bankruptcy.
RBBN has a worse Altman-Z score (-0.45) than 70.83% of its industry peers.
RBBN has a debt to FCF ratio of 43.32. This is a negative value and a sign of low solvency as RBBN would need 43.32 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 43.32, RBBN is in line with its industry, outperforming 41.67% of the companies in the same industry.
RBBN has a Debt/Equity ratio of 0.88. This is a neutral value indicating RBBN is somewhat dependend on debt financing.
RBBN's Debt to Equity ratio of 0.88 is on the low side compared to the rest of the industry. RBBN is outperformed by 72.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 43.32
Altman-Z -0.45
ROIC/WACC0.29
WACC10.88%
RBBN Yearly LT Debt VS Equity VS FCFRBBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

RBBN has a Current Ratio of 1.38. This is a normal value and indicates that RBBN is financially healthy and should not expect problems in meeting its short term obligations.
RBBN has a Current ratio of 1.38. This is in the lower half of the industry: RBBN underperforms 75.00% of its industry peers.
RBBN has a Quick Ratio of 1.14. This is a normal value and indicates that RBBN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RBBN (1.14) is worse than 64.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.14
RBBN Yearly Current Assets VS Current LiabilitesRBBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.52% over the past year.
Measured over the past years, RBBN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.59% on average per year.
RBBN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.68%.
The Revenue has been growing by 8.17% on average over the past years. This is quite good.
EPS 1Y (TTM)9.52%
EPS 3Y-7.9%
EPS 5Y-12.59%
EPS Q2Q%0%
Revenue 1Y (TTM)7.68%
Revenue growth 3Y-0.44%
Revenue growth 5Y8.17%
Sales Q2Q%14.52%

3.2 Future

Based on estimates for the next years, RBBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.50% on average per year.
Based on estimates for the next years, RBBN will show a small growth in Revenue. The Revenue will grow by 5.83% on average per year.
EPS Next Y6.08%
EPS Next 2Y19.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.14%
Revenue Next 2Y5.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RBBN Yearly Revenue VS EstimatesRBBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
RBBN Yearly EPS VS EstimatesRBBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

RBBN is valuated correctly with a Price/Earnings ratio of 16.67.
Compared to the rest of the industry, the Price/Earnings ratio of RBBN indicates a somewhat cheap valuation: RBBN is cheaper than 75.00% of the companies listed in the same industry.
RBBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.93.
RBBN is valuated reasonably with a Price/Forward Earnings ratio of 10.74.
Based on the Price/Forward Earnings ratio, RBBN is valued cheaply inside the industry as 89.58% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of RBBN to the average of the S&P500 Index (35.31), we can say RBBN is valued rather cheaply.
Industry RankSector Rank
PE 16.67
Fwd PE 10.74
RBBN Price Earnings VS Forward Price EarningsRBBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RBBN indicates a somewhat cheap valuation: RBBN is cheaper than 77.08% of the companies listed in the same industry.
RBBN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 87.46
EV/EBITDA 10.32
RBBN Per share dataRBBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RBBN does not grow enough to justify the current Price/Earnings ratio.
RBBN's earnings are expected to grow with 19.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.74
PEG (5Y)N/A
EPS Next 2Y19.5%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RBBN!.
Industry RankSector Rank
Dividend Yield N/A

RIBBON COMMUNICATIONS INC

NASDAQ:RBBN (8/15/2025, 1:14:47 PM)

3.835

-0.12 (-2.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners73.4%
Inst Owner Change0.55%
Ins Owners2.6%
Ins Owner Change9.94%
Market Cap679.10M
Analysts81.54
Price Target6.2 (61.67%)
Short Float %1.88%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-7.27%
Max Revenue beat(2)1.35%
Revenue beat(4)2
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-7.27%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-4.4%
Revenue beat(12)2
Avg Revenue beat(12)-3.88%
Revenue beat(16)2
Avg Revenue beat(16)-4.18%
PT rev (1m)3.11%
PT rev (3m)3.11%
EPS NQ rev (1m)-18%
EPS NQ rev (3m)-12.4%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.71%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 16.67
Fwd PE 10.74
P/S 0.79
P/FCF 87.46
P/OCF 15.95
P/B 1.83
P/tB N/A
EV/EBITDA 10.32
EPS(TTM)0.23
EY6%
EPS(NY)0.36
Fwd EY9.31%
FCF(TTM)0.04
FCFY1.14%
OCF(TTM)0.24
OCFY6.27%
SpS4.88
BVpS2.09
TBVpS-0.54
PEG (NY)2.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.89%
ROE -11.98%
ROCE 3.94%
ROIC 3.11%
ROICexc 3.36%
ROICexgc 8.53%
OM 3.78%
PM (TTM) N/A
GM 51.12%
FCFM 0.9%
ROA(3y)-6.09%
ROA(5y)-5.14%
ROE(3y)-15.65%
ROE(5y)-13.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y14.11%
ROICexcg growth 5Y27.22%
ROICexc growth 3Y23.03%
ROICexc growth 5Y37.6%
OM growth 3Y16.11%
OM growth 5Y34.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.05%
GM growth 5Y-1.31%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 43.32
Debt/EBITDA 3.46
Cap/Depr 56.27%
Cap/Sales 4.03%
Interest Coverage 0.82
Cash Conversion 45.04%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.14
Altman-Z -0.45
F-Score6
WACC10.88%
ROIC/WACC0.29
Cap/Depr(3y)22.21%
Cap/Depr(5y)24.26%
Cap/Sales(3y)1.85%
Cap/Sales(5y)2.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.52%
EPS 3Y-7.9%
EPS 5Y-12.59%
EPS Q2Q%0%
EPS Next Y6.08%
EPS Next 2Y19.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.68%
Revenue growth 3Y-0.44%
Revenue growth 5Y8.17%
Sales Q2Q%14.52%
Revenue Next Year6.14%
Revenue Next 2Y5.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y127.01%
EBIT growth 3Y15.6%
EBIT growth 5Y45.12%
EBIT Next Year31.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y268.8%
FCF growth 3Y135.34%
FCF growth 5Y-9.42%
OCF growth 1Y545.27%
OCF growth 3Y37.8%
OCF growth 5Y-2.04%